Prenatal Genetic Screening Test Market

The Global "Prenatal Genetic Screening Test Market" was valued at USD 8.75 Billion in 2023 and is projected to reach USD 14.72 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 7.2% during the forecast period (2024-2030). The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Prenatal genetic screening tests are medical procedures performed during pregnancy to assess the risk of the fetus having certain genetic disorders or chromosomal abnormalities. These tests help in early detection and informed decision-making about potential health issues.

• Influence of COVID-19: The estimation of market sizes has taken into account the impact of the COVID-19 pandemic, affecting healthcare priorities, patient access, and the adoption of genetic screening tests.

• Impact of the Russia-Ukraine War: The ongoing conflict between Russia and Ukraine has been factored into the market analysis, influencing global economic conditions and healthcare funding.

• Drivers of Growth: Key drivers of market growth include rising awareness of prenatal care, advancements in genetic screening technologies, increasing maternal age, and the growing incidence of genetic disorders.

• Technological Advancements: Progress in non-invasive prenatal testing (NIPT) and other genetic screening technologies is enhancing test accuracy, safety, and convenience.

• Government and Healthcare Policies: Supportive government policies and healthcare guidelines promoting prenatal screening are expected to drive market expansion.

• Challenges: Market growth faces challenges such as high costs of advanced screening tests, limited access in developing regions, and ethical concerns surrounding genetic testing and prenatal screening.

• Regional Insights: North America and Europe are expected to dominate the market due to advanced healthcare infrastructure and higher adoption rates, while the Asia-Pacific region is projected to experience significant growth driven by increasing healthcare investments and awareness.

The global key manufacturers of Prenatal Genetic Screening Test include bioMrieux S.A., Biocartis Bioscience, GeneSTAT Molecular Diagnostics, Meridian Bioscience, Quidel Corporation, F. Hoffman-La Roche, Danaher, AccuBioTech and Abbott, etc. in 2023, the global top five players have a share approximately % in terms of revenue.

• Global Prenatal Genetic Screening Test Market Revenue, 2019-2024, 2025-2030, ($ millions)
• Global top five companies in 2023 (%)

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prenatal Genetic Screening Test companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Prenatal Genetic Screening Test Market, by Type, 2019-2024, 2025-2030 ($ millions)

Global Prenatal Genetic Screening Test Market Segment Percentages, by Type, 2023 (%)

• Carrier Screening
• Sequential Screening
• Maternal Serum Quad Screening

Global Prenatal Genetic Screening Test Market, by Application, 2019-2024, 2025-2030 ($ millions)

Global Prenatal Genetic Screening Test Market Segment Percentages, by Application, 2023 (%)

• Hospitals
• Clinics
• Diagnostic Centers

Global Prenatal Genetic Screening Test Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)

Global Prenatal Genetic Screening Test Market Segment Percentages, By Region and Country, 2023 (%)

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

The report also provides analysis of leading market participants including:

• Key companies Prenatal Genetic Screening Test revenues in global market, 2019-2024 (estimated), ($ millions)
• Key companies Prenatal Genetic Screening Test revenues share in global market, 2023 (%)

Further, the report presents profiles of competitors in the market, key players include:

• bioMrieux S.A.
• Biocartis Bioscience
• GeneSTAT Molecular Diagnostics
• Meridian Bioscience
• Quidel Corporation
• F. Hoffman-La Roche
• Danaher
• AccuBioTech
• Abbott
• DiaSorin S.p.A
• Siemens Healthineers AG
• Terumo Corporation
• Grifols, S.A
• BD
• Chembio Diagnostics
• EKF Diagnostics
• Trinity Biotech
• Instrumentation Laboratory
• Nova Biomedical
• PTS Diagnostics
• Sekisui Diagnostics
• Thermo Fisher Scientific

Outline of Major Chapters:

Chapter 1: Introduces the definition of Prenatal Genetic Screening Test, market overview.

Chapter 2: Global Prenatal Genetic Screening Test market size in revenue.

Chapter 3: Detailed analysis of Prenatal Genetic Screening Test company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Prenatal Genetic Screening Test in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: The main points and conclusions of the report.